# CONT-AR03 — AR-03 Closure and First Human Test Continuity Realignment

## Result

Continuity realignment completed on the provided repository archive, declared base `5a08d5d`.

AR-03 is recorded as **CLOSED** with AR-03G verdict:

**B — AR-03 CLOSED; FIRST HUMAN TEST MAY PROCEED WITH EXPLICIT SUPERVISED LIMITATIONS.**

**FIRST HUMAN TEST GATE: OPEN WITH EXPLICIT TEST LIMITATIONS.**

The next product objective is **PREPARE AND EXECUTE THE FIRST SUPERVISED HUMAN TEST**. No AR-03H / AR-03I is introduced.

## Repository-first authority review

The current continuity index identifies `README.md`, `CONTINUITY.md` and `NEXT_PHASE.md` as current authority surfaces relevant to this realignment. `README.md` itself contained an obsolete description of `NEXT_PHASE.md` (E-43 complete / E-44 sole planned gate), so leaving it untouched would have preserved a current-authority contradiction.

`CORE_ARCHITECTURE.md` and `DECISIONS.md` remain unchanged: their E-43 verification markers describe their Core architecture / ADR scope and AR-03G does not change those contracts. Historical review files and non-indexed readiness material were not rewritten.

## Changes

- `docs/00-continuity/README.md`: realignment date updated and `NEXT_PHASE.md` authority description aligned to the First Human Test gate.
- `docs/00-continuity/CONTINUITY.md`: current verified state consolidated around AR-03 closure, model-execution variability, fail-closed behavior, supervised First Human Test limitations, and deferred E-44. The obsolete statement that live Groq verification had not occurred is removed from the current view rather than extended with a task diary.
- `docs/00-continuity/NEXT_PHASE.md`: replaced stale E-43 / Beta-journey implementation priority with the approved next product objective and operating limitations.

No production code, tests, Product Authority, semantic policy, validator/schema, Knowledge projection, UI, E-44 implementation or Git history was modified.

## Consolidated current state

Residual `contextual-none` and `shared` failures are classified as **MODEL EXECUTION VARIABILITY**. Incomplete `SUPPORTED` candidates are rejected; `UNSUPPORTED` does not produce a positive Observation; rejected/incomplete candidates are not repaired or converted into Knowledge. No fallback, retry, majority voting, validator relaxation or Knowledge repair is authorized.

The supervised First Human Test must preserve Evidence → semantic executor outcome → Observation provenance, record provider/model and executor outcome, expose rejected/unsupported results as not enough evidence / not established, avoid Measurement/Knowledge conclusions when projection is unavailable, collect human disagreement, treat run-to-run variability as calibration evidence, and not present the test as production reliability validation.

Deferred Core work, including `0100E-44`, remains deferred unless explicitly consumed by the active product path.

## Verification

- whitespace/error check: PASS using `git diff --no-index --check` against pristine copies because the supplied archive contains no `.git` metadata;
- modified-document internal consistency: PASS;
- no current AR-03G contradiction in the modified authority surfaces: PASS;
- no modification outside the continuity realignment: PASS;
- application tests: not run, as no code was modified.

No commit or push was performed.
